Literature DB >> 1681848

Pharmacokinetics and safety of cicloprolol in uraemic patients.

J P Fillastre, M Aparicio, C Porquet, C Dubruc, P Rosenzweig, P L Morselli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1681848      PMCID： PMC1368458          DOI： 10.1111/j.1365-2125.1991.tb03896.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  High-performance liquid and gas chromatographic methods for the determination of cicloprolol.

Authors:  P Guinebault; A Haddouche; G Bianchetti
Journal:  J Chromatogr       Date:  1990-02-23

2.  [Hemodynamic effects at rest and exertion of a new partial beta-agonist (cicloprolol) in moderated cardiac failure].

Authors:  M Rigaud; V Hamoir; A Chabanier; E Neveux; J L Cazor; J Bardet; J P Bourdarias
Journal:  Arch Mal Coeur Vaiss       Date:  1988-10

Review 3.  [Pharmacokinetics of anti-hypertensive drugs in renal failure].

Authors:  T Hannedouche; J P Fillastre
Journal:  Nephrologie       Date:  1986

4.  Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.

Authors:  P E Hicks; I Cavero; P Manoury; F Lefevre-Borg; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

5.  Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.

Authors:  W Kirch; I Rose; H G Demers; G Leopold; J Pabst; E E Ohnhaus
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

6.  Studies of the agonist and antagonist activity of cicloprolol in man.

Authors:  P M McCaffrey; M Burke; J G Riddell; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance.

Authors:  C D Payton; J G Fox; N F Pauleau; J M Boulton-Jones; C Ioannides; A Johnston; P Thomas
Journal:  Eur Heart J       Date:  1987-12       Impact factor: 29.983

8.  Haemodynamic dose-response actions of cicloprolol in left ventricular dysfunction due to ischaemic heart disease.

Authors:  B Silke; S P Verma; S K Sharma; W Baig; N C Jackson; G Reynolds; M A Frais; S H Taylor
Journal:  Int J Cardiol       Date:  1987-11       Impact factor: 4.164
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.